A study is currently being conducted by the University of North Carolina, Chapel hill and National Institute on Drug Abuse (NIDA) to understand the effect of GLP-1 receptor agonists on nicotine response and smoking behaviour on dependent smokers
[18] [22] In December 2025, an oral version of semaglutide, sold under the brand name Wegovy, was approved in the US for weight management
These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications
At Bruce Wellness & Aesthetics, we understand that accurate body composition analysis is crucial for any successful weight loss program, whether medical or surgical
1,4 This is not a comprehensive list of the possible interactions with psyllium husk